Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Pediatrix Medical Group, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-57.1% vs price
Base Case (Median)
6.6% vs price
Bull Case (75th pct.)
62.7% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $7.78 | -71.0% | High (40%) |
| PE Comparable | $46.64 | 74.0% | Medium (25%) |
| Growth Trajectory DCF | $89.01 | 232.1% | Medium (20%) |
| Graham Number | $22.64 | -15.5% | Medium (40%) |
| EV/EBITDA | $34.52 | 28.8% | Medium (20%) |
| Earnings Power Value | $3.79 | -85.9% | Medium (50%) |
Based on 6 out of 8 methods, MD appears fairly valued at the current price of $26.80. The base case fair value of $28.58 implies 6.6% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.
